MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    STN-DBS Frequency Effects in Parkinson’s: An fMRI Study

    A. Vijayakumari, C. Piccinin, J. Alberts, P. Bhattacharya, M. Lowe, B. Walter (Cleveland, USA)

    Objective: The study aimed to investigate the impact of deep brain stimulation (DBS) at varying frequencies on brain activation patterns during a motor (force-tracking [FT])…
  • 2024 International Congress

    Analysis of structural connectivity in relation to change in dopaminergic medication after 6 months of STN-DBS in Parkinson´s disease – a pilot study

    š. Janovič, D. Kroneberg, B. Al-Fatly, A. Kušnírová, Z. Košutzká (Bratislava, Slovakia)

    Objective: To describe the relationship between structural connectivity and it´s effect on change in levodopa equivalent daily dose (LEDD) in patients 6 months after subthalamic…
  • 2024 International Congress

    Mapping the distribution of neurotransmitters to resting-state functional connectivity in patients with Parkinson’s disease

    W. Li, N. Lao-Kaim, R. Li, A. Martín-Bastida, A. Roussakis, G. Searle, N. Valle-Guzman, V. Dayal, D. Athauda, Z. Kefalopoulou, P. Mahlknecht, A. Church, K. Peall, H. Widner, G. Paul, T. Foltynie, R. Barker, P. Piccini (London, United Kingdom)

    Objective: To examine the associations between functional connectivity (FC), as measured by resting-state functional magnetic resonance imaging (rs-fMRI), and the spatial distribution of dopamine and…
  • 2024 International Congress

    Identification of Brain Atrophy Subtypes in Prodromal and Overt Synucleinopathies: A Multicenter Study

    S. Joza, A. Delva, C. Tremblay, A. Vo, J-F. Gagnon, R. Postuma, P. Dusek, M. Hu, J. Klein, J-P. Taylor, J. O'Brien, M. Firbank, A. Thomas, P. Donaghy, S. Lehericy, I. Arnulf, M. Vidailhet, J-C. Corvol, M. Sommerauer, S. Röttgen, S. Lewis, E. Matar, K. Ehgoetz Martens, L. Churchill, R. Camicioli, H. Chertkow, P. Borghammer, K. Knudsen, A. Hansen, D. Arnaldi, B. Orso, P. Matiioli, A. Dagher, S. Rahayel (Montreal, Canada)

    Objective: To identify unique subtypes of synucleinopathy with distinct spatiotemporal patterns and trajectories of brain atrophy and disease burden. Background: The synucleinopathies manifest as a…
  • 2024 International Congress

    Resting-State Network Alterations in Patients with Isolated REM Sleep Behavior Disorder and their Association with Clinical Symptoms

    I. Roura, J. Pardo, J. Oltra, A. Campabadal, Y. Compta, N. Bargallo, M. Serradell, C. Junqué, A. Iranzo, B. Segura (Barcelona, Spain)

    Objective: To characterize brain functional connectivity (FC) in patients with isolated REM sleep behavior disorder (iRBD) and its associations with clinical features. Background: Patients with…
  • 2024 International Congress

    Early GBA-Related Parkinson’s Disease has a Distinct Clinical Phenotype and Cholinergic Innervation

    S. Slingerland, S. Zee, G. Carli, A. Slomp, E. D'Angremont, J. Boertien, T. Laar (Groningen, Netherlands)

    Objective: This study aims to characterize the clinical features and cholinergic innervation of early Parkinson’s disease (PD) patients with GBA mutations (GBA-PD). Background: The GBA-PD…
  • 2024 International Congress

    The Impact of Drug Interactions on the results of DAT-SPECT Imaging in a Specialty Movement Disorders Practice: A Retrospective Analysis of Outcomes

    I. Kang, D. Bega (Chicago, USA)

    Objective: This study was a retrospective chart review of patients who underwent DAT-SPECT imaging for parkinsonism while on drugs listed as potentially interacting with the…
  • 2024 International Congress

    Differentiating Progressive Supranuclear Palsy from Corticobasal Syndrome Using Cortical Diffusion MRI

    M. Torso, G. Ridgway, I. Hardingham, S. Chance (Oxford, United Kingdom)

    Objective: To compare cortical microstructural measures in Progressive Supranuclear Palsy (PSP) and Corticobasal Syndrome (CBS) using cortical diffusion magnetic resonance imaging (MRI). Background: Differential diagnosis…
  • 2024 International Congress

    Polyamine pathways: a promising frontier for biomarkers and therapeutic targets in Parkinson’s disease (PD)

    W-L. Tsou, P. Lewitt, B. Ranxhi, Z. Chbihi, Z. Bangash, S. Todi (Detroit, USA)

    Objective: To systematically modulate polyamine (PA) metabolic pathways and investigate PA biomarker findings in PD using Drosophila melanogaster over-expressing human wild-type α-synuclein gene (hSNCA). Our…
  • 2024 International Congress

    Levodopa-Entacapone-Carbidopa Intestinal Gel in the treatment of advanced Parkinson’s disease: a two-year experience

    J. Szász, V. Constantin, K. Orbán-Kis, S. Bataga, R. Neagoe, M. Ciorba, I. Mihaly, K. Kelemen, S. Szatmári (Targu Mures, Romania)

    Objective: To evaluate the efficacy of Levodopa-Entacapone-Carbidopa Intestinal Gel (LECIG) in the treatment of patients with advanced Parkinson’s Disease (APD). Background: The continuous enteral infusion…
  • « Previous Page
  • 1
  • …
  • 429
  • 430
  • 431
  • 432
  • 433
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley